Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
65 /100
HIGH RISK
Score updated Oct 27, 2026

BFRI — Biofrontera Inc. Dilution Risk Tracker

Track BFRI dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track BFRI — Get alerts when the score changes →

As of October 27, 2026, Biofrontera Inc. (BFRI) has a DilutionWatch DilutionScore of 65/100, rated HIGH dilution risk. Biofrontera Inc. has a market capitalization of $12.33M, 14.85M shares outstanding, 12 institutional holders tracked. Stored dilution-related fields include 2.27M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
85
📊 Float Risk
52
⚠️ Warrant Exposure
50
🔄 Convertible Debt
40

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 50%
🔄 Reverse Split model est. 70%
• 50-day avg $0.97 below $1 exchange minimum
• Only 5 months cash — financial pressure
💰 Capital Raise model 35%
• Low cash runway: 5 months remaining
📜 Warrant Exercise model 25%
• Significant warrants: 15% of shares outstanding
🔔 Track BFRI — Get forecast alerts →

Market Data

Market Cap$12.33M
Shares Outstanding14.85M
Float8.06M
Cash$4.66M
Debt$296.0K
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore65/100DilutionWatch score record
Shares Outstanding14.85MVerified float table or market cache
Public Float8.06MVerified float table or market cache
Market Cap$12.33MMarket data cache
Cash Runway5.0 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants2.27MSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 4 5, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

BFRI SEC Filing Activity — Last 12 Months

Shares outstanding reported by BFRI on the cover page of its latest 10-K/10-Q: 14.85M as of August 11, 2026.

DilutionWatch recorded 1 registration or prospectus document for BFRI (the filings through which shares are offered) in the last 12 months. Full filing list on SEC EDGAR →

FormWhat it isFilingsMost recent
S-1registration statement (IPO / follow-on)1Dec 05, 2025
EFFECTSEC declared a registration effective1Dec 19, 2025
8-Kcurrent report (material event)13Sep 14, 2026
10-Kannual report1Jul 22, 2026
DEF 14Aproxy statement1Apr 30, 2026
SC 13G/Aamended passive >5% holder filing1Aug 12, 2026
5annual insider ownership10Jul 29, 2026

Institutional Holdings

QoQ: ↑ 4.6% shares (2026Q1 vs prior)
12 institutional holders · 2.44M shares
#1 Rosalind Advisors, Inc. 1.16M shares
#2 AIGH Capital Management LLC 915.2K shares
#3 GEODE CAPITAL MANAGEMENT, LLC 109.3K shares
+ 9 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest103.1K
Days to Cover1.0
% of Float1.3%
FINRA data as of Oct 15, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-08-13
xbrl XBRL CONVERTIBLE 2026-08-13
4 INSIDER TRANSACTION 2026-03-06
4 INSIDER TRANSACTION 2026-03-06
4 INSIDER TRANSACTION 2026-03-06
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual BFRI Dilution Snapshot

Biofrontera Inc. (BFRI) has a DilutionScore of 65/100, rated High dilution risk. Score date: October 27, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

BFRI's DilutionScore is currently 65/100 (High risk), with 3 score changes tracked over 89 days. The score improved from 62/100 (High risk).

Period Score Risk Level Duration
Sep 28 – Oct 27, 202665/100HIGH30 days
Aug 22 – Sep 27, 202662/100HIGH37 days
Aug 14 – Aug 21, 202654/100HIGH7 days
Jul 30 – Aug 13, 202659/100HIGH15 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

BFRI shares outstanding have increased 9.9% from 11.65M (Mar 2026) to 12.80M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 23, 202612.80M8.06M▼ 0.28%
May 16, 202612.01M8.08M▲ 1.70%
Mar 10, 202611.65M7.95M▼ 2.75%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track BFRI Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment BFRI files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking BFRI — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,566+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for BFRI
BFRI FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.